Form 4 for APVO Aptevo Therapeutics Inc.
Accepted 2024-08-09 00:00:00 ET · period of report 2024-08-08 · accession 0000950170-24-094813 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-08-09 | 2024-08-08 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | — | +158 | 576 | +38% | — |
| D | 2024-08-09 | 2024-08-08 | APVO | Taylor Daphne | SVP, CFO | M - OptEx | $0.00 | -158 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-08 | M | A | 158 | — | 576 | D | — | — | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Unit | 2024-08-08 | M | D | 158 | $0.00 | 0 | D | — · — to — | 158 Common Stock | (F1) Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis. (F2) On August 9, 2022, the reporting person was granted 13,889 (315 post-split) RSUs, vesting in two approximately equal annual installments beginning on August 8, 2023. |